| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.17 | 0.2 |